- HK$6.30bn
- HK$6.63bn
- CNY627.73m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 333 | 424 | 421 | 541 | 628 |
Cost of Revenue | |||||
Gross Profit | 293 | 313 | 224 | 261 | 383 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 325 | 366 | 383 | 233 | 744 |
Operating Profit | 8.2 | 58.2 | 37.7 | 307 | -116 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 5.13 | 51.9 | 91.1 | 283 | -140 |
Provision for Income Taxes | |||||
Net Income After Taxes | 13.9 | 80 | 98 | 280 | -145 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 10.8 | 81.3 | 94.2 | 282 | -146 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 10.8 | 81.3 | 94.2 | 282 | -146 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.014 | 0.033 | 0.034 | 0.029 | -0.024 |